| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/24/2008 | US20080096824 administering oligopeptides to prevent apoptosis in stroke, heart attack or ischemia patients and patients having degenerative diseases, infection caused by bacteria, viruses or protozoa, and reduce side effects of chemotherapy and radiotherapy |
| 04/24/2008 | US20080096816 Orally administered peptides synergize statin activity |
| 04/24/2008 | US20080096815 Orally administered peptides synergize statin activity |
| 04/24/2008 | US20080096814 Orally administered peptides synergize statin activity |
| 04/24/2008 | US20080096812 isolation of low molecular weight proteins from connective tissue of animals, by dissolving in an aqueous solution of alkali compounds, for use in foods and drugs such as anticoagulants or anticholesterol agents |
| 04/24/2008 | US20080096805 deoxygenated, endotoxin-free and stroma-free transport proteins, incapable of binding with nitric oxide, useful as substitutes for erythrocytes in mammals and for treating disorders where oxygen delivery agents are of benefit |
| 04/24/2008 | US20080095841 Such as amlodipine besylate, iron oxide and carrageenan; storage stability |
| 04/24/2008 | US20080095835 Cyclin dependent kinase inhibitors; gene expression inhibition; cell differentiation; immunotherapy; cytokines |
| 04/24/2008 | US20080095824 Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space |
| 04/24/2008 | US20080095821 Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response |
| 04/24/2008 | US20080095788 Vaccines |
| 04/24/2008 | US20080095773 Polypeptides homologous to vegf and bmp1 |
| 04/24/2008 | US20080095762 Glycoprotein compositions |
| 04/24/2008 | US20080095760 Using fibrinolytic metalloproteinase composition to treat and prevent cardiovascular disorders |
| 04/24/2008 | US20080095751 Atherosclerosis |
| 04/24/2008 | US20080095749 Mesenchymal stem cells and uses therefor |
| 04/24/2008 | US20080095714 Administering metallic nanoparticles to localize in macrophages to overcome the cooling effect of blood flow on the plaque, heating such nanoparticles with a pulsed laser, and imaging the temperature differences; ultrasound or optical coherence tomography imaging systems; atherosclerosis; diagnosis |
| 04/24/2008 | US20080095711 Modulators of Pulmonary Hypertension |
| 04/24/2008 | DE102006049837A1 Use of core-shell or hollow microparticles containing superparamagnetic nanoparticles to treat blood vessel defects by application of a magnetic field |
| 04/24/2008 | CA2800405A1 Antidepressant, neuroprotectant, amyloid .beta. deposition inhibitor or age retardant containing heterocyclic compound having specific structure |
| 04/24/2008 | CA2672926A1 Bicyclic heteroaromatic compounds |
| 04/24/2008 | CA2666508A1 Quinoline compounds |
| 04/24/2008 | CA2665376A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the .beta.2 adrenergic receptor |
| 04/23/2008 | EP1914310A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/23/2008 | EP1914237A2 Phosphonate ester antiviral compounds |
| 04/23/2008 | EP1914233A1 Peripherally-selective inhibitors of dopamine-b-hydroxylase and method of their preparation |
| 04/23/2008 | EP1914232A1 N-dihydroxyalkyl-substituted 2-oxoimidazole derivative |
| 04/23/2008 | EP1913949A1 Modulation of substrate preference by selective translocation of the major cardiac glucose transporter Glut4 |
| 04/23/2008 | EP1913942A2 The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma |
| 04/23/2008 | EP1912993A1 Xanthine derivatives as selective hm74a agonists |
| 04/23/2008 | EP1912992A1 Xanthine derivatives as selective hm74a agonists |
| 04/23/2008 | EP1912991A1 Xanthine derivatives as selective hm74a agonists |
| 04/23/2008 | EP1912949A1 Cyclohexylamin isoquinolone derivatives as rho-kinase inhibitors |
| 04/23/2008 | EP1912666A2 Use of amylin and amylin agonists as cardioprotective or myoprotective agents |
| 04/23/2008 | EP1912638A2 Composition of n-3 fatty acids having high concentration of epa and/or dha and containing n-6 fatty acids |
| 04/23/2008 | EP1912635A2 Use of chk2 kinase inhibitors for cancer treatment |
| 04/23/2008 | EP1812412B1 Substituted benzoylguanidines method for production and use thereof as medicament or diagnostic and medicament comprising the same |
| 04/23/2008 | EP1802578B1 3,6-substituted 5-arylamino-1h-pyidine-2-one derivatives and related compounds as poly(adp-ribose)polymerase (parp) inhibitors in the treatment of tissue damage or disease caused by necrosis or apoptosis |
| 04/23/2008 | EP1474145B1 Quinoline derivatives as npy antagonists |
| 04/23/2008 | EP1420643B1 Enhancement of transfection of dna into the liver |
| 04/23/2008 | EP1216230B1 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 04/23/2008 | EP1177289B1 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use |
| 04/23/2008 | EP1007033B1 Lymphocyte function antigen-1 antagonists |
| 04/23/2008 | EP0998459B1 Pyridine derivatives |
| 04/23/2008 | EP0984928B1 Heterocyclic nitrato derivatives |
| 04/23/2008 | EP0763116B2 Recombinant viruses, preparation and use thereof in gene therapy |
| 04/23/2008 | CN101166762A Albumin-fused Kunitz domain peptides |
| 04/23/2008 | CN101166756A Pyrimidine derivatives and their use as p2y12 receptor antagonists |
| 04/23/2008 | CN101166742A Novel lactam compound |
| 04/23/2008 | CN101166730A Cinnoline compounds and their use as liver X receptor modilators |
| 04/23/2008 | CN101166523A Methods of treating atherosclerosis |
| 04/23/2008 | CN101166484A Materials and methods for treating and managing plaque disease |
| 04/23/2008 | CN101165053A N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion |
| 04/23/2008 | CN101165052A N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion |
| 04/23/2008 | CN101165036A Ether compounds, compositions, and uses thereof |
| 04/23/2008 | CN101164619A Pyritinol injection with special purpose solvent |
| 04/23/2008 | CN101164618A A combination of fbpase inhibitors and insulin sensitizers for the treatment of diabetes |
| 04/23/2008 | CN101164616A Uses of anti-insulin-like growth factor 1 receptor antibodies |
| 04/23/2008 | CN101164608A Traditional Chinese medicine composition for treating high blood pressure and preparation process thereof |
| 04/23/2008 | CN101164607A Traditional Chinese medicine for treating palpitation discomfort and easily short breath |
| 04/23/2008 | CN101164589A Traditional Chinese medicine for treating bradycardia palpitation |
| 04/23/2008 | CN101164588A Traditional Chinese medicine for treating yin deficiency and fire excess type palpitation |
| 04/23/2008 | CN101164587A Traditional Chinese medicine for treating palpitation restless and dyspnea chest discomfort |
| 04/23/2008 | CN101164570A Traditional Chinese medicine for treating melancholy spirit-injuring palpitation |
| 04/23/2008 | CN101164567A Traditional Chinese medicine pillow pad for lowering blood pressure |
| 04/23/2008 | CN101164566A Peony leaves total glycoside extract, its preparation method and application |
| 04/23/2008 | CN101164563A Traditional Chinese medicine historical preparation for treating coronary heart disease and angina pectoris |
| 04/23/2008 | CN101164562A Traditional Chinese medicine historical preparation for treating apoplexy |
| 04/23/2008 | CN101164546A Vein-relaxing pain-relieving medicinal composition and preparation method and use thereof |
| 04/23/2008 | CN101164540A Application of marine steroids compound in preparing medicine for treating neuronal damage |
| 04/23/2008 | CN100383163C Antibody for inhibiting blood coagulation and method of use thereof |
| 04/23/2008 | CN100383141C Pyrazolo [4,3-d] pyrimidine derivatives |
| 04/23/2008 | CN100383140C Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 04/23/2008 | CN100383139C Piperidine-2,6-dione derivatives capable of inhibiting cell from releasing tumor necrosis factor |
| 04/23/2008 | CN100383132C Azoles as malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 04/23/2008 | CN100383126C Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 04/23/2008 | CN100383124C Quinoline derivatives as NPY antagonists |
| 04/23/2008 | CN100382813C Pressure lowering maijunan capsule and its preparation method |
| 04/23/2008 | CN100382812C Chinese medicine for lowering blood pressure and its preparation method |
| 04/23/2008 | CN100382784C Danhong drip pill prepared from salvia root and carthamus and its preparation method |
| 04/23/2008 | CN100382713C Bagged tea of eucommia bark |
| 04/22/2008 | US7361787 Prophylaxis of respiratory disorders and therapy, also metod of synthesis and composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent |
| 04/22/2008 | US7361783 Agonists for human PPAR alpha isoform; exhibit lipid-lowering effect, inhibitory effect on the arteriosclerosis, antiobesity effect, blood glucose-lowering effect; 2-{[3-(N-{[4-(3,5-bistrifluoromethylphenoxy)phenyl]methyl}carbamoyl)-4-methoxyphenyl]methyl}butyric acid |
| 04/22/2008 | US7361758 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist |
| 04/22/2008 | US7361748 Protease for identifying modulators for treatment and prevention of thrombocytopenia and liver disorders |
| 04/22/2008 | US7361687 Antagonists of the B2 receptor of bradykinin; analgesics; hyperalgesia and major algesia; cancer; nontoxic; industrial scale; 5-[[(2,4-dichloro-3-methylphenyl)sulphonyl]methylamino]-N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-N-methyl-pentanamide |
| 04/22/2008 | US7361684 Screening of compounds for treatment of atherosclerosis and heart attack |
| 04/22/2008 | US7361678 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 04/22/2008 | US7361670 Amide derivatives as NMDA receptor antagonists |
| 04/22/2008 | US7361669 particularly useful for treating cardiovascular disease |
| 04/22/2008 | US7361668 Quinuclidine derivatives processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors |
| 04/22/2008 | US7361664 For therapy of cancer, hyperparathyroidism, vascular calcification, bone disease, renal failure or kidney stones, psoriasis |
| 04/22/2008 | US7361663 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa |
| 04/22/2008 | US7361662 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same |
| 04/22/2008 | US7361655 Pharmaceutically effective compounds |
| 04/22/2008 | US7361652 βd-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 04/22/2008 | US7361651 Procoralan; brandycardial agent: angina pectoris, myocardial infarct, heart failure, myocardial ischaemia, supraventricular rhythm disturbances; stability and processability |
| 04/22/2008 | US7361650 γ-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 04/22/2008 | US7361649 β-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 04/22/2008 | US7361648 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |